The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease-Reference-Cited by-同舟云学术

The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease

Published:2015-02-16 Issue:3 Volume:21 Page:263-269
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Youm Yun-Hee,Nguyen Kim Y,Grant Ryan W,Goldberg Emily L,Bodogai Monica,Kim Dongin,D'Agostino Dominic,Planavsky Noah,Lupfer Christopher,Kanneganti Thirumala D,Kang Seokwon,Horvath Tamas L,Fahmy Tarek M,Crawford Peter A,Biragyn Arya,Alnemri Emad,Dixit Vishwa Deep

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3804.pdf

Reference36 articles.

1. Newman, J.C. & Verdin, E. Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 25, 42–52 (2014).

2. Cotter, D.G., Schugar, R.C. & Crawford, P.A. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 304, H1060–H1076 (2013).

3. Shido, O., Nagasaka, T. & Watanabe, T. Blunted febrile response to intravenous endotoxin in starved rats. J. Appl. Physiol. 67, 963–969 (1989).

4. Johnson, J.B. et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 42, 665–674 (2007).

5. Mercken, E.M. et al. Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 12, 645–651 (2013).

Cited by 1484 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of single or conjoint administration of poly-β-hydroxybutyrate and Bacillus subtilis on growth, antioxidant capacity and apoptosis of common carp (Cyprinus carpio);Animal Feed Science and Technology;2024-12

2. β-Hydroxybutyrate alleviates brain aging through the MTA1 pathway in D-galactose injured mice;European Journal of Pharmacology;2024-11

3. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

4. ADORA3 activation promotes goblet cell differentiation via enhancing HMGCS2-mediated ketogenesis in ulcerative colitis;International Immunopharmacology;2024-10

5. Pathophysiological role and potential drug target of NLRP3 inflammasome in the metabolic disorders;Cellular Signalling;2024-10